Mag-aso, Alwina L.
HRN: 21-46-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2022
MUPIROCIN 2%, 15G (TUBE)
06/15/2022
06/22/2022
TOPICAL
Apply Thinly
BID
Abrasions
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes